Ed Esplin, MD, PhD retweeted
🏆 Maureen Mork from @UTMDAnderson was not only the very deserving recipient of the 2026 Dennis J. Ahnen Outstanding Service Award at #CGAIGC26, but also delivered an insightful presentation on an important topic, "Novel Approaches to Genetic Testing."
Ms Mork shared insights nge of low cascade genetic testing uptake among at-risk relatives and explored potential strategies to improve participation.
🔹 Innovative approaches include patient navigation, reducing financial barriers, and at-home genetic testing.
🔹 No single intervention has consistently achieved the desired results, highlighting the need for creative, multimodal approaches to improve testing uptake.
🎥 Watch this short interview 👇to hear Ms Mork's key takeaways and what they mean for the multidisciplinary #hereditarygicancer care team.
#CascadeTesting #GeneticCounseling
Ms Mork shared insights nge of low cascade genetic testing uptake among at-risk relatives and explored potential strategies to improve participation.
🔹 Innovative approaches include patient navigation, reducing financial barriers, and at-home genetic testing.
🔹 No single intervention has consistently achieved the desired results, highlighting the need for creative, multimodal approaches to improve testing uptake.
🎥 Watch this short interview 👇to hear Ms Mork's key takeaways and what they mean for the multidisciplinary #hereditarygicancer care team.
#CascadeTesting #GeneticCounseling
0
2
5
99
Ed Esplin, MD, PhD retweeted
📣We're excited to kick off #PancreaticCancerAwarenessMonth & sharing exciting advances in pancreatic cancer treatment!
At #CGAIGC26, Dr. Lindsay Davis, a medical oncologist from the @CUCancerCenter highlights emerging treatment options, including PARP inhibitors, immunew KRAS-targeted therapies.
With KRAS mutations found in approximately 93% of pancreatic cancers, these developments offer new hope for more personalized treatment approaches & improved patient outcomes.
📽️Watch this short sound bite 👇 to hear Dr. Davis share the latest developments & what they could mean for patients!
At #CGAIGC26, Dr. Lindsay Davis, a medical oncologist from the @CUCancerCenter highlights emerging treatment options, including PARP inhibitors, immunew KRAS-targeted therapies.
With KRAS mutations found in approximately 93% of pancreatic cancers, these developments offer new hope for more personalized treatment approaches & improved patient outcomes.
📽️Watch this short sound bite 👇 to hear Dr. Davis share the latest developments & what they could mean for patients!
0
3
5
172
Ed Esplin, MD, PhD retweeted
🎥 Does AI-assisted colonoscopy improve lesion detection in patients with #LynchSsyndrome?
At #CGAIGC26, @RHuneburg from University Hospital Bonn, Germany, shares findings from the CADLY-2 trial, published in The Lancet Gastroenterology & Hepatology
Watch this short video 👇 to hd their implications for Lynch syndrome surveillance.
#hereditarygicancer
At #CGAIGC26, @RHuneburg from University Hospital Bonn, Germany, shares findings from the CADLY-2 trial, published in The Lancet Gastroenterology & Hepatology
Watch this short video 👇 to hd their implications for Lynch syndrome surveillance.
#hereditarygicancer
1
4
5
275
Ed Esplin, MD, PhD retweeted
🎥 Missed the Randall Burt Lecture at #CGAIGC26 or couldn't join us in Denver?
🙏to our Communications Committee member Benjamin Lerner, MD who caught up with James Ford, MD following his Randall Burt Lecture, “A Pre-Cancer Atlas for Hereditary Colorectal Cancer: Using FAP as a is insightful interview, Dr. Ford shares insights into how familial adenomatous polyposis (FAP) can serve as a model for understanding the earliest stages of colorectal cancer development and the potential implications for future cancer prevention strategies.
🎧 Take a few minutes to listen to this fascinating conversation and hear directly from Dr. Ford!
#HereditaryGICancer #CancerResearch
@MSpringerGC @EdEsplin @asaf_maoz @HHampel1 @AparajitaSingh0
🙏to our Communications Committee member Benjamin Lerner, MD who caught up with James Ford, MD following his Randall Burt Lecture, “A Pre-Cancer Atlas for Hereditary Colorectal Cancer: Using FAP as a is insightful interview, Dr. Ford shares insights into how familial adenomatous polyposis (FAP) can serve as a model for understanding the earliest stages of colorectal cancer development and the potential implications for future cancer prevention strategies.
🎧 Take a few minutes to listen to this fascinating conversation and hear directly from Dr. Ford!
#HereditaryGICancer #CancerResearch
@MSpringerGC @EdEsplin @asaf_maoz @HHampel1 @AparajitaSingh0
0
1
5
200
Privileged to join #DrJimFord @Stanford & #DrSteveGruber @cityofhope at the @CGAIGC #RandallBurtLecture highlighting work done by the @Stanford #PreCancerAtlas for #FamilialAdenomatousPolyposis #CGAIGC26
0
0
4
268
Dr. Jim Ford presents @Stanford #PreCancerAtlas #FAP as #DrRandallBurt Lecture,
"A Pre-Cancer Atlas for Hereditary #ColorectalCancer Using #FamilialAdenomatousPolyposis as a Model System: #MultiOmic Analysis Toward #Prevention of #CRC"
to a packed house at @CGAIGC #CGAIGC26
"A Pre-Cancer Atlas for Hereditary #ColorectalCancer Using #FamilialAdenomatousPolyposis as a Model System: #MultiOmic Analysis Toward #Prevention of #CRC"
to a packed house at @CGAIGC #CGAIGC26
1
0
6
364
@Stanford @Nature @Stanford #PreCancerAtlas #FAP acheived the ultimate goal of @NIH #HTAN using #spatial #transcriptomics & #proteomics to generate a #multiscale #3D #atlas of an #FAP #polyp #Han et al
1
0
0
33
@Stanford @Nature @NIH Dr. Ford highlighted that all #FAP multiomic data, generated by the amazing @Stanford #PreCancerAtlas #FAP team is available at data.humantumoratlas.org
Great opening for @CGAIGC Annual Meeting's 30th Anniversary! #CGAIGC26
Great opening for @CGAIGC Annual Meeting's 30th Anniversary! #CGAIGC26
0
0
0
36
Ed Esplin, MD, PhD retweeted
@thegimonster & @IdosGreg with Dan Luba announcing the recipients of the @projectDNA_org @cityofhope Clinical Cancer Genomics Community of Practice scholarships. Training the future generation of cancer genetics experts! #CGAIGC26
0
1
4
250
#Genetictesting is an integral part of the evaluation of children w/ #cardiomyopathy
30-50% pediatric #patients w/ #HCM #RCM #DCM #LVNC have PGVs on #genetictesting
growing number of #genetherapies strengthens the case for early #genetic diagnosis, as #genetictesting not only prognosis but also #treatment
Critical to ensure that the benefits of #genetictesting reach all children w/ #cardiomyopathy & their families
cit. "Comprehensive #GeneticTesting for #Pediatric #HypertrophicCardiomyopathy Reveals Clinical Management Opportunities & Syndromic Conditions" #DanaGal et al #PediatricCardiology @SpringerNature link.springer.com/article/10.100…
#Universal #germline #genetictesting for all #patients w/ #cardiomyopathy
#access #reducedisparities #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention
mdpi.com/2073-4425/17/1… #IulianaZaharia et al #Genes @MDPIOpenAccess
30-50% pediatric #patients w/ #HCM #RCM #DCM #LVNC have PGVs on #genetictesting
growing number of #genetherapies strengthens the case for early #genetic diagnosis, as #genetictesting not only prognosis but also #treatment
Critical to ensure that the benefits of #genetictesting reach all children w/ #cardiomyopathy & their families
cit. "Comprehensive #GeneticTesting for #Pediatric #HypertrophicCardiomyopathy Reveals Clinical Management Opportunities & Syndromic Conditions" #DanaGal et al #PediatricCardiology @SpringerNature link.springer.com/article/10.100…
#Universal #germline #genetictesting for all #patients w/ #cardiomyopathy
#access #reducedisparities #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention
mdpi.com/2073-4425/17/1… #IulianaZaharia et al #Genes @MDPIOpenAccess
0
1
3
220
Ed Esplin, MD, PhD retweeted
🔬 5 presenters. 5 research perspectives. One shared goal: improving Lynch syndrome care.
Discover the research featured in the CCARE Lynch Syndrome Poster Walk at #CGAIGC26!
📌 Meet the presenters and explore their work:
🔹 Guillermo Alberto
Clinical and Molecular ch Syndrome: Experience from an Argentinian Specialized Oncology Center
🔹 Alessandro Mannucci
Impact of Cecal Retroflexion on Adenoma Detection for Lynch Syndrome Surveillance Colonoscopy
🔹 Devang Namjoshi
How Are Patients with Lynch Syndrome (LS) Informed About Aspirin (ASA) Chemoprevention by Genetic Counselors (GCS), and What Factors Influence Communication Behaviors?
🔹 Desha Perera
Downstream Uptake of Cancer Risk Management Among Lynch Syndrome Patients
🔹 Drew Pitter
Building a Lynch Syndrome Specific Psychosocial Support Program: Practical Lessons from a Psychologist Led Group Model
📅 November 2 | 3:05 – 3:35 PM
🔗 Explore the scientific program: bit.ly/3TZtxPj
Discover the research featured in the CCARE Lynch Syndrome Poster Walk at #CGAIGC26!
📌 Meet the presenters and explore their work:
🔹 Guillermo Alberto
Clinical and Molecular ch Syndrome: Experience from an Argentinian Specialized Oncology Center
🔹 Alessandro Mannucci
Impact of Cecal Retroflexion on Adenoma Detection for Lynch Syndrome Surveillance Colonoscopy
🔹 Devang Namjoshi
How Are Patients with Lynch Syndrome (LS) Informed About Aspirin (ASA) Chemoprevention by Genetic Counselors (GCS), and What Factors Influence Communication Behaviors?
🔹 Desha Perera
Downstream Uptake of Cancer Risk Management Among Lynch Syndrome Patients
🔹 Drew Pitter
Building a Lynch Syndrome Specific Psychosocial Support Program: Practical Lessons from a Psychologist Led Group Model
📅 November 2 | 3:05 – 3:35 PM
🔗 Explore the scientific program: bit.ly/3TZtxPj
0
4
7
388
Ed Esplin, MD, PhD retweeted
🏆 The champions are back… but can they defend their title?
An annual #CGAIGC26 favorite returns to Denver, and the competition is heating up! 🔥
The Lynch Pins and Frameshift Express are ready to challenge the defending champions, The Uninhibited Checkpoints, in this year’s vember 3 | 5:00 – 6:00 PM
🔗 Explore the scientific program: bit.ly/3TZtxPj
Proudly supported by Ambry Genetics, a Tempus company.
An annual #CGAIGC26 favorite returns to Denver, and the competition is heating up! 🔥
The Lynch Pins and Frameshift Express are ready to challenge the defending champions, The Uninhibited Checkpoints, in this year’s vember 3 | 5:00 – 6:00 PM
🔗 Explore the scientific program: bit.ly/3TZtxPj
Proudly supported by Ambry Genetics, a Tempus company.
0
1
3
250
Ed Esplin, MD, PhD retweeted
How are advances in treatment, prevention, and surgical care changing the management of polyposis syndromes?
At #CGAIGC26, Dr. Leah Biller, Dr. Jeongyoon Moon, and Dr. Ajay Bansal will explore evolving approaches to polyposis care, from therapy-associated polyposis and lowing colorectal surgery to the latest evidence in chemoprevention.
🔗 Learn more about our speakers and their presentations:
Dr. Leah Biller: bit.ly/4i9BUkH
Dr. Jeongyoon Moon: bit.ly/48mF3Yx
Dr. Ajay Bansal: bit.ly/4iiaJ6d
📅 November 4 | 10:45 AM – 12:15 PM
At #CGAIGC26, Dr. Leah Biller, Dr. Jeongyoon Moon, and Dr. Ajay Bansal will explore evolving approaches to polyposis care, from therapy-associated polyposis and lowing colorectal surgery to the latest evidence in chemoprevention.
🔗 Learn more about our speakers and their presentations:
Dr. Leah Biller: bit.ly/4i9BUkH
Dr. Jeongyoon Moon: bit.ly/48mF3Yx
Dr. Ajay Bansal: bit.ly/4iiaJ6d
📅 November 4 | 10:45 AM – 12:15 PM
0
7
9
301
Ed Esplin, MD, PhD retweeted
1/ Welcome to the #CGAIGCJC Tweetorial on “Shared inheritance reveals landscape of somatic and germline cancer risk in TP53” MacGregor et al, by our Communications Committee member @annalstrang
➡️Published in American Journal of Human Genetics 👉pubmed.ncbi.nlm.nih.gov/42607671/
🧵
#HereditaryGICancer
➡️Published in American Journal of Human Genetics 👉pubmed.ncbi.nlm.nih.gov/42607671/
🧵
#HereditaryGICancer
1
3
4
296